ArticleBulletin of the World Health Organization2026
National guideline development and adaptation, Egypt.
Article in Bulletin of the World Health Organization, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Problem: In 2018, the Egyptian government enacted a universal health coverage law mandating provision of high-quality, effective and equitable health care. Achieving this mandate would require expanding availability and use of evidence-based national clinical practice and public health guidelines. Approach: In 2022, Egypt's Ministry of Health and Population requested support from the World Health Organization (WHO) to establish a national guideline development and adaptation programme. To inform the process, WHO conducted a situation analysis. The findings led to a collaboration between WHO and national stakeholders including the newly established Egyptian Health Council. In partnership they delivered capacity-building, developed a roadmap and implemented the programme. Local setting: Egypt is a lower-middle income country of 117 million people. Health services are provided by agencies in public (governmental and semi-governmental) and private sectors (providers and professional syndicates). No national guideline programme existed before 2022. Relevant changes: In total, 225 individuals attended the capacity-building workshops. After the council ratified the roadmap, the ministry, WHO and the council formally launched the national guideline programme in July 2024. Implementation of the programme led to clearer delineation of responsibilities, eliminated role overlaps and harmonized processes across different professional societies, teaching hospitals, nurses and allied health professionals. Lessons learnt: Consistent, informed political support and stakeholder commitment contributed to successful implementation. WHO's approach to contextualizing global guidelines added value. Challenges included reliance on international experts, constrained resources and insufficient institutional capacity. Moving forward, sustained institutional development, coaching, monitoring and evaluation, funding and stakeholder engagement are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.